Patents Assigned to Shanghai CP Guojian Pharmaceutical Co., Ltd.
  • Publication number: 20110111495
    Abstract: This invention discloses a kind of concentrated medium for large-scale culture of Chinese Hamster Ovary cell. The said medium comprises basic medium and high dose additives. This invention also discloses the method of adding the described concentrated medium in large-scale fed-batch culture of CHO cells.
    Type: Application
    Filed: April 18, 2008
    Publication date: May 12, 2011
    Applicant: SHANGHAI CP GUOJIAN PHARMACEUTICAL CO. LTD
    Inventors: Yajun Guo, Hao Wang, Geng Kou, Hui Hu, Sheng Hou, Min Tan
  • Patent number: 7666609
    Abstract: This invention relates to monoclonal antibodies that recognize an antigen specific to melanocytic lesions. These antibodies are useful in methods of isolating melanoma cells and diagnosing melanocytic lesions. These antibodies are also useful for immunotherapy against melanoma.
    Type: Grant
    Filed: July 26, 2001
    Date of Patent: February 23, 2010
    Assignee: Shanghai CP GuoJian Pharmaceutical Co. Ltd.
    Inventors: Yajun Guo, Jing Ma
  • Patent number: 6805869
    Abstract: The present invention provides a method for enhancing the immunogenicity of weakly immunogenic or non-immunogenic cells, resulting in a cellular vaccine that can stimulate T cell activation, which in turn leads to an effective immune response. The cellular vaccines of the present invention are useful for the prevention and treatment of diseases which develop and/or persist by escaping the immune response triggered by T cell activation. Such diseases include, for example, all cancers, natural and induced immune deficiency states, and diseases caused by infections with a variety of pathogens.
    Type: Grant
    Filed: December 17, 1998
    Date of Patent: October 19, 2004
    Assignee: Shanghai CP Guojian Pharmaceutical Co., Ltd.
    Inventor: Yajun Guo